Cite
P-139 The impact of immunohistochemical expression of p53 protein on phenotypic characteristics in patients with myelodisplastic syndromes (MDS).
MLA
Duarte, F., et al. “P-139 The Impact of Immunohistochemical Expression of P53 Protein on Phenotypic Characteristics in Patients with Myelodisplastic Syndromes (MDS).” Leukemia Research, vol. 37, May 2013, p. S86. EBSCOhost, https://doi.org/10.1016/S0145-2126(13)70187-5.
APA
Duarte, F., Filho, F., Barbosa, M., Santos, T., Cunha, A., Gon, R., & Vasconcelos, P. (2013). P-139 The impact of immunohistochemical expression of p53 protein on phenotypic characteristics in patients with myelodisplastic syndromes (MDS). Leukemia Research, 37, S86. https://doi.org/10.1016/S0145-2126(13)70187-5
Chicago
Duarte, F., F. Filho, M. Barbosa, T. Santos, A. Cunha, R. Gon, and P. Vasconcelos. 2013. “P-139 The Impact of Immunohistochemical Expression of P53 Protein on Phenotypic Characteristics in Patients with Myelodisplastic Syndromes (MDS).” Leukemia Research 37 (May): S86. doi:10.1016/S0145-2126(13)70187-5.